The Pharmaceutics experts at Charles River work closely with the chemistry, biology and DMPK teams to provide essential information on the physical properties of compounds in order to help direct medicinal chemistry activities and to de-risk candidate molecules with respect to their pharmaceutical developability.

Acquisition of Argenta & BioFocus

This acquisition positions us as an early-stage CRO with in vitro and in vivo capabilities from target identification and validation through preclinical development. Learn more »

I need to...